1. Home
  2. LX vs NAGE Comparison

LX vs NAGE Comparison

Compare LX & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LX
  • NAGE
  • Stock Information
  • Founded
  • LX 2013
  • NAGE 1999
  • Country
  • LX China
  • NAGE United States
  • Employees
  • LX N/A
  • NAGE N/A
  • Industry
  • LX Finance: Consumer Services
  • NAGE Medicinal Chemicals and Botanical Products
  • Sector
  • LX Finance
  • NAGE Health Care
  • Exchange
  • LX Nasdaq
  • NAGE Nasdaq
  • Market Cap
  • LX 843.0M
  • NAGE 766.4M
  • IPO Year
  • LX 2017
  • NAGE N/A
  • Fundamental
  • Price
  • LX $5.71
  • NAGE $7.60
  • Analyst Decision
  • LX
  • NAGE Strong Buy
  • Analyst Count
  • LX 0
  • NAGE 3
  • Target Price
  • LX N/A
  • NAGE $17.00
  • AVG Volume (30 Days)
  • LX 2.6M
  • NAGE 1.3M
  • Earning Date
  • LX 11-24-2025
  • NAGE 11-04-2025
  • Dividend Yield
  • LX 6.79%
  • NAGE N/A
  • EPS Growth
  • LX 86.38
  • NAGE N/A
  • EPS
  • LX 1.28
  • NAGE 0.22
  • Revenue
  • LX $1,956,013,429.00
  • NAGE $116,303,000.00
  • Revenue This Year
  • LX $6.40
  • NAGE $28.91
  • Revenue Next Year
  • LX $17.75
  • NAGE $20.89
  • P/E Ratio
  • LX $4.46
  • NAGE $35.17
  • Revenue Growth
  • LX 0.80
  • NAGE 35.90
  • 52 Week Low
  • LX $3.01
  • NAGE $3.42
  • 52 Week High
  • LX $11.64
  • NAGE $14.69
  • Technical
  • Relative Strength Index (RSI)
  • LX 57.79
  • NAGE 41.76
  • Support Level
  • LX $4.93
  • NAGE $7.17
  • Resistance Level
  • LX $5.13
  • NAGE $7.59
  • Average True Range (ATR)
  • LX 0.26
  • NAGE 0.33
  • MACD
  • LX 0.11
  • NAGE 0.08
  • Stochastic Oscillator
  • LX 77.56
  • NAGE 75.00

About LX LexinFintech Holdings Ltd.

LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.

About NAGE Niagen Bioscience Inc. Common Stock

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Share on Social Networks: